Dallas, TX and San Francisco, CA (August 29, 2022) Pharmaceutical Strategies Group (PSG), an EPIC company, announced an enhancement of its data and analytics platform, Artemetrx®,…
Results in PSG’s latest benefit design research reveal an increased focus on member satisfaction DALLAS, Tex. – New research on the latest trends in benefit design launches today. Pharmaceutical…
NEW PRODUCT LAUNCH: Pharmaceutical Strategies Group Launches Artemetrx Rebate Monitor Improved oversight of PBM rebates via Artemetrx Rebate Monitor protects the financial interests of health…
Specialty trend increasing at a slower pace but maintains double-digit growth in PSG’s fifth annual integrated pharmacy and medical benefit report DALLAS, Tex. – Pharmaceutical…
Newly published peer-reviewed research in the Journal of Occupational and Environmental Medicine found that companies with a culture of health outperform the stock market (as expressed by…
Results of comprehensive PBM customer satisfaction research released by Pharmaceutical Strategies Group PSG’s Pharmacy Benefit Manager (PBM) Customer Satisfaction report explores more than 40 dimensions…
Modernized Integrated Data Technology Platform, Artemetrx, Now Available to Proactively Manage Drug Costs and Clinical Outcomes Innovative health tech transforms integrated pharmacy and medical data…
Pharmaceutical Strategies Group Unveils Solution to Double Drug Cost Savings “PSG Complete” is the latest in a series of drug management innovations from PSG DALLAS–(…
EPIC announced today that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation’s largest independent…
New opportunity to proactively manage the total cost of diabetes care with integrated data on the powerful Artemetrx technology platform PLANO, Texas–(BUSINESS WIRE)–Pharmaceutical Strategies…